Cancer Research Cancer Medicine 8  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 3386-3393, July 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taetle, R.
Right arrow Articles by Segarini, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taetle, R.
Right arrow Articles by Segarini, P.

Effects of Transforming Growth Factor ß1 on Growth and Apoptosis of Human Acute Myelogenous Leukemia Cells1

Raymond Taetle2, Claire Payne, Betty Dos Santos, Melinda Russell and Patricia Segarini

Departments of Medicine and Pathology, Arizona Health Sciences Center, and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 [R. T., C. P., B. D. S., M. R.]; and Celtrix Pharmaceuticals, Inc., Santa Clara, California 94052 [P. S.]

Because limited studies examined effects of transforming growth factor (TGF) ß1 on growth of human acute myelogenous leukemia (AML) cells, we used factor-dependent and primary AML cells to assess TGF-ß1 effects on human AML cell growth. OCI-AML1 cells were growth inhibited by TGF-ß1 regardless of which growth factor was used as a stimulus. In contrast, AML-193 cells were resistant to TGF-ß1 when grown with or without growth factors. UCSD/AML1 cells were sensitive to TGF-ß1 inhibition when grown with most cytokines but were relatively resistant to TGF-ß1 in the presence of macrophage colony-stimulating factor (M-CSF). Although cells grown from 5 of 6 AML patients were inhibited by TGF-ß1, cells from 1 AML patient were growth stimulated by TGF-ß1 in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF, or mast cell growth factor (kit ligand). Thus, 3 growth patterns with TGF-ß1 were observed: (a) sensitivity to growth inhibition; (b) resistance; and (c) factor-dependent resistance. Further studies showed that AML-193 and UCSD/AML1 cells expressed type II TGF-ß1 receptors and that ability of TGF-ß1 to decrease GM-CSF receptors did not correlate with growth inhibition. AML-193 cells and UCSD/AML1 cells grown with M-CSF could be propagated in 1 ng/ml TGF-ß1, but UCSD/AML1 cells grown with GM-CSF and TGF-ß1 died. Morphology and agarose gel analysis of DNA showed UCSD/AML1 cells underwent apoptosis when grown with GM-CSF and TGF-ß1 but not with M-CSF and TGF-ß1. Similar studies of OCI-AML1 cells showed that TGF-ß1 induced apoptosis of cells grown in 5637 bladder cell-conditioned medium or GM-CSF. These studies indicate that human AML cells exhibit heterogeneous growth responses to TGF-ß1 and that some effects of TGF-ß1 on myeloid cells occur through programmed cell death.

1 This work supported in part by NIH National Cancer Institute Grants CA32094 and CA23074.

2 To whom requests for reprints should be addressed, at 1515 N. Campbell Ave., Tucson, AZ 85724.

Received 12/ 7/92. Accepted 5/11/93.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Ghannam, A. Takeda, T. Camarata, M. A. Moore, A. Viale, and N. R. Yaseen
The Oncogene Nup98-HOXA9 Induces Gene Transcription in Myeloid Cells
J. Biol. Chem., January 9, 2004; 279(2): 866 - 875.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis
Blood, September 15, 2000; 96(6): 2022 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld
TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation
J. Cell Sci., January 2, 2000; 113(3): 383 - 390.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
C. Oliveira, R. Seruca, M. Seixas, and M. Sobrinho-Simoes
The Clinicopathological Features of Gastric Carcinomas with Microsatellite Instability May Be Mediated by Mutations of Different ""Target Genes"" : A Study of the TGFß RII, IGFII R, and BAX Genes
Am. J. Pathol., October 1, 1998; 153(4): 1211 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Saeki, A. Yuo, M. Kato, K. Miyazono, Y. Yazaki, and F. Takaku
Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor beta 1 and Overexpression of Bcl-2
J. Biol. Chem., August 8, 1997; 272(32): 20003 - 20010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Francis, C. M. Heyworth, E. Spooncer, A. Pierce, T. M. Dexter, and A. D. Whetton
Transforming Growth Factor-beta 1 Induces Apoptosis Independently of p53 and Selectively Reduces Expression of Bcl-2 in Multipotent Hematopoietic Cells
J. Biol. Chem., December 8, 2000; 275(50): 39137 - 39145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.